Stereotaxis Inc. (Nasdaq: STXS) and Westmead Hospital in Australia announced
that the Niobe system formed faster, deeper lesions in highly mobile
cardiac regions. The stock price rose 23 cents to close at $1.80.
Positive data for Stereotaxis’ Niobe system
August 28, 2015 at 10:37 AM EDT
